Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI114304
National Institutes of Health
Grant: R01AI145679
National Institutes of Health
Grant: K24AI155045
National Institutes of Health
Grant: K24AI114444
National Institutes of Health
Grant: P30AI124414
National Institutes of Health
Grant: P30AI050409
National Institutes of Health
Grant: U19AI111211
National Institutes of Health
Grant: UL1TR001073
National Institutes of Health
Grant: UL1TR000454
National Institutes of Health
Grant: K43TW011421
European and Developing Countries Clinical Trials Partnership
Grant: CDF1018
Wellcome Trust
Grant: 203135/Z/16/Z
Wellcome Trust
Grant: 098316
Defining interventions to reduce mortality in severe HIV-associated tuberculosis.
Wellcome Trust
Grant: 214321/Z/18/Z
National Research Foundation of South Africa
Grant: 64787
TB and HIV Collaborating Centres Programme
Grant: TB/HIV/AIDS-01-2014
NCATS NIH HHS
Grant: UL1 TR002556
Wellcome Trust
Grant: 203135
Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
National Institutes of Health
Grant: 5P30AI050409-20
Center for AIDS Research at Emory University
National Institutes of Health
Grant: 5K24AI114444-02
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
National Institutes of Health
Grant: 1UL1TR001073-01
Clinical and Translational Science Award
National Institutes of Health
Grant: 1R01AI114304-01A1
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
National Institutes of Health
Grant: 1R01AI145679-01A1
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting
National Institutes of Health
Grant: 1K24AI155045-01
Mentoring of multidisciplinary global health research in tuberculosis and HIV
National Institutes of Health
Grant: 2P30AI124414-07
ERC Einstein-Rockefeller-CUNY Center for AIDS research
National Institutes of Health
Grant: 5U19AI111211-04
Role of antigen-specific T cell responses in the control of TB
National Institutes of Health
Grant: 1K43TW011421-01
Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis
National Institutes of Health
Grant: 5UL1TR000454-07
Atlanta Clinical and Translational Science Institute (ACTSI) Renewal
Wellcome Trust
Grant: 214321
Evaluation of novel therapeutic strategies to accelerate bacterial clearance and host recovery in disseminated HIV-associated tuberculosis
South African Medical Research Council
National Institute of Allergy and Infectious Diseases
South African Research Chairs Initiative of the Department of Science and Technology
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
Additional file 1 of Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis